34
Participants
Start Date
February 28, 2011
Primary Completion Date
September 30, 2011
Study Completion Date
October 31, 2011
morphine LO
intravenous infusion, 10 mg, once, 4 hours
Morphine Hi
intravenous infusion, 20 mg, once, 4 hours
Buprenorphine LO
intravenous infusion, 0.3 mg, once, 4 hours
Buprenorphine Hi
intravenous infusion, 0.6 mg, once, 4 hours
saline
intravenous infusion, 0.9% saline, once, 4 hours
Zelo Phase One Clinical Trial Unit, Bispebjerg Hospital, Copenhagen NV
Collaborators (1)
Norpharma A/S
INDUSTRY
mads u werner
OTHER